PathAI is developing technology that assists pathologists in making rapid and accurate diagnoses for every patient, every time.
PathAI’s services solve challenging pathology problems faced by the research and pharmaceutical industry. The PathAI platform provides end-to-end automation for reliable, scalable, and cost-effective long-term solutions. PathAI is developing technology that assists pathologists in making rapid and accurate diagnoses for every patient, every time.The company was founded in 2016 and based in Boston, Massachusetts.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
May 18, 2021 | Series C | $165M | 3 | Kaiser Permanente | — | Detail |
Nov 4, 2019 | Series B | $15M | 1 | LabCorp | — | Detail |
Apr 17, 2019 | Series B | $60M | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Kaiser Permanente | Yes | Series C |
LabCorp | — | Series C |
General Catalyst | — | Series C |